Search

Your search keyword '"Holger Moch"' showing total 911 results

Search Constraints

Start Over You searched for: Author "Holger Moch" Remove constraint Author: "Holger Moch"
911 results on '"Holger Moch"'

Search Results

151. Supplementary Figure 6 from Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth

152. Supplementary Table 1 from Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney

153. Supplementary Figure 4 from Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth

154. Supplementary Methods from Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney

155. Supplementary Table 2 from Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney

156. Supplementary Figures 1 - 6 from Tumor Suppressor VHL Functions in the Control of Mitotic Fidelity

157. Supplementary Figure 5 from Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth

158. Supplementary Figure 2 from Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth

159. Utility of BAP1, p16 and MTAP immunohistochemistry in cytological and histological samples of pleural mesotheliomas

161. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification

162. CanIsoNet: a database to study the functional impact of isoform switching events in diseases

164. Vaccination with designed neopeptides induces intratumoral, cross-reactive CD4+ T cell responses in glioblastoma

165. ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

166. Onkozytäre Tumoren der Niere – neue Differenzialdiagnosen

167. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours

168. A systematic comparison of pan-Trk immunohistochemistry assays across multiple cancer types

169. Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment

175. What’s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns

176. What's new in WHO fifth edition - urinary tract

177. Access and quality of biomarker testing for precision oncology in Europe

178. Histologische Subtypen des Nierenzellkarzinoms

179. Towards a new WHO classification of renal cell tumor: what the clinician needs to know—a narrative review

180. The Role of Frozen Section Examination During Inguinal Exploration in Men with Inconclusive Testicular Tumors: A Systematic Review and Meta-analysis

181. CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer

182. Tracing Clonal Dynamics Reveals that Two- and Three-dimensional Patient-derived Cell Models Capture Tumor Heterogeneity of Clear Cell Renal Cell Carcinoma

183. Chromophobe renal cell carcinoma: current and controversial issues

185. Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design

186. WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer

187. An introduction to the WHO 5th edition 2022 classification of testicular tumours

188. MALDI Mass Spectrometry Imaging—Prognostic Pathways and Metabolites for Renal Cell Carcinomas

189. Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study

190. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors

191. Two distinct immunopathological profiles in autopsy lungs of COVID-19

192. Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy

193. Granular necrosis: a distinctive form of cell death in malignant tumours

194. CME-Sonografie 89: Differenzialdiagnose von Nierenraumforderungen

195. The single-cell pathology landscape of breast cancer

196. Machine learning with autophagy-related proteins for discriminating renal cell carcinoma subtypes

197. Integrated Analysis Of Immunotherapy Treated Clear Cell Renal Cell Carcinomas: An Exploratory Study

198. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors

199. Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.07.002

200. Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study

Catalog

Books, media, physical & digital resources